The PILMA partners adopted the following statement on May 27, 2020: Download the statement here. For 15 years, labor unions in North America’s Building Trades and companies in the biopharmaceutical industry have developed and advanced a partnership, formalized as the Pharmaceutical Industry Labor-Management Association (PILMA). The biopharmaceutical industry is a vital sector in the United […]
News
PILMA Partners Commit to Fighting COVID-19
Views ways PILMA’s labor and industry partners are committing to fighting COVID-19. View the biopharmaceutical industry’s principles to beat COVID-19. During the COVID-19 pandemic, the long-standing partnership between the biopharmaceutical industry and highly skilled union construction workers has become ever more important. The PILMA partnership’s mission to create quality union construction jobs, foster innovation, and […]
Data shows half of all spending on brand medicines is retained by manufacturer
Last year, PILMA in collaboration with union health care and benefits expert Randy DeFrehn released a report titled “An Understanding and Implications of the Cost Drivers in the Drug Supply Chain.” PILMA combined DeFrehn’s findings with data from a new report by Berkeley Research Group to extrapolate on the original report and provide insight into which entities in the supply chain are receiving an increasing share of revenue from prescription medicines.
PILMA Statement on House Drug Pricing Proposal
On September 19, 2019, PILMA released the following statement raising concerns with H.R. 3, the House drug pricing proposal. Download the statement here. The Pharmaceutical Industry Labor-Management Association (PILMA), a coalition of biopharmaceutical companies and skilled construction labor unions, has grave concerns with H.R. 3, the House Democrats drug pricing proposal. If passed, this proposal […]
PILMA Statement on the Trump Administration’s Exploration of Biopharmaceutical Importation
On July 31, 2019, PILMA released the following statement regarding an announcement by the Trump Administration exploring drug importation from Canada. Download the statement here. The Pharmaceutical Industry Labor-Management Association (PILMA) has a long and steadfast history of opposing the importation of biopharmaceuticals from other countries. Bad policies can take any form, whether as importation […]
PILMA Statement on the Prescription Drug Reduction Act of 2019
On July 23, 2019, PILMA released the following statement regarding the Senate Finance Committee mark-up and consideration of the Prescription Drug Reduction Act of 2019. Download the statement here. For 15 years, labor unions in North America’s Building Trades and companies in the biopharmaceutical industry have enjoyed a robust partnership, formalized as the Pharmaceutical Industry […]